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After publication of the original article [1], it came to 
the authors’ attention that there was an error in the final 
paragraph of the Discussion section. The word ‘not’ was 
accidently omitted from the following sentence: “With 
three large in  vivo experiments and in  vitro experi-
ments involving the human pathogen, it does seem likely 
that liraglutide interacts adversely with P. falciparum in 
humans.”
The sentence should therefore have read as follows: 
“With three large in vivo experiments and in vitro experi-
ments involving the human pathogen, it does not seem 
likely that liraglutide interacts adversely with P. falcipa-
rum in humans.”
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